Ecolab has made an offer to acquire Bioquell, a provider of hydrogen peroxide vapor bio-decontamination systems and services for the life sciences and healthcare industries. Headquartered in Andover, U.K., Bioquell’s 2017 sales were approximately £29 million ($37 million).
Bioquell’s bio-decontamination and isolator technologies and services help ensure residue-free surface decontamination in cleanrooms and research and development labs at biotech start-ups, pharmaceutical manufacturers and Fortune 500 companies, and in patient rooms at hospitals in more than 50 countries.
Under the terms of Ecolab’s offer, Bioquell shareholders will receive 590 pence per share.
The transaction, if approved by Bioquell shareholders, is expected to close in the first quarter of 2019, subject to satisfaction of customary closing conditions and regulatory clearance.